Clinical Trial Update: Dose-escalation Study to Assess Safety, Tolerability and Pharmacokinetics of MEDI-573 in Japanese Subjects [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation study evaluating safety, tolerability, and pharmacokinetics of MEDI-573 in Japanese subjects with cancer or advanced solid malignancies;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Solid Malignancies

Drugs mentioned

• MEDI-573

Snippet

Sponsor: AstraZeneca | Conditions: Cancer, Advanced Solid Malignancies | Phase 1 | Status: COMPLETED